CardioBra is a two-part system, uniquely designed to work with Claravue electrodes by Nissha Medical Technologies. CardioBra used with Claravue reinforces electrode adherence and promotes ECG lead placement under the breast with added support. Claravue's low-profile pre-wired design eliminates the pinch clips allowing for a comfortable fit. Womens heart health. Female stress testing.
News | Womens Cardiovascular Health
Kansas Cardiologist Improves the Stress Test Experience for Women With ECG Bra

March 8, 2021 — University of Kansas Health System Cardiologist Ashley Simmons, M.D., knew there could and should be a ...

Home March 08, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)
CRT May Benefit More Heart Failure Patients in New Analysis of REVERSE Trial

March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...

Home March 03, 2021
Home
Impulse Dynamics Optimizer Smart device is an implantable device that helps optimize cardiac pumping action in heart failure patients.
News | Heart Failure
European Union Allows MRI Scans of Heart Failure Patients With Impulse Dynamics Implanted Optimizer Smart Devices

March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization ...

Home March 03, 2021
Home
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.
News | Cardiac Diagnostics
AliveCor Collaborates With AstraZeneca to Develop Noninvasive Potassium Monitoring Solutions

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
News | Atrial Fibrillation
First AF Patients Treated With Farapulse Pulsed Field Ablation System

March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug ...

Home March 03, 2021
Home
LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center. 
News | Heart Failure
Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD

March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant a ...

Home March 02, 2021
Home
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries
News | Ventricular Assist Devices (VAD)
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries

March 1, 2021 — Medtronic is recalling the HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit because the left ...

Home March 01, 2021
Home
The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.
Feature | By Dave Fornell, Editor
Most Popular Cardiology Technology Content in February 2021 

March 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home March 01, 2021
Home
FDA Clears Third COVID-19 Vaccine From Janssen, Johnson and Johnson, J&J
News | Coronavirus (COVID-19)
FDA Clears Third COVID-19 Vaccine From Janssen

March 1, 2021 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the third ...

Home March 01, 2021
Home
The first COVID-19 patient in the world was supported by the new Abiomed Breethe OXY-1 System at Hackensack University Medical Center.
News | ECMO Systems
Hackensack University Medical Center First Hospital in the World to Use New ECMO Technology to Treat COVID-19

February 25, 2021 — The first COVID-19 patient in the world was supported by the new Abiomed Breethe OXY-1 System, an ...

Home February 25, 2021
Home
Astronaut Jessica Meir “feeds” a set of the University of Washington’s engineered heart tissues (inside the green-topped case at center) riding aboard the International Space Station as part of a test of micro-gravity on heart health. Image courtesy of NASA. 
Feature | Stem Cell Therapies | By Andy Freeberg
Tiny Beating Hearts Created With Stem Cells at the University of Washington

The University of Washington (UW) in Seattle has developed engineered heart tissue that beats. Though minuscule, the ...

Home February 25, 2021
Home
An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents.  Cardio-oncology
News | Cardio-oncology
Global Longitudinal Strain Echo Offers Early Detection of Cardiotoxicity Heart Damage From Chemotherapy

February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) ...

Home February 25, 2021
Home
The January-February 2021 digital issue of DAIC magazine. Dave Fornell is the editor
Feature
The DAIC January-February 2021 Digital Edition

View the January-February 2021 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, include ...

Home February 24, 2021
Home
UK hospU.K. hospital admissions for heart attacks and heart failure were reduced by more than 50 percent in the spring of 2020 and by more than a third in the second wave of COVID-19 as people fear going to hospitals and ignore serious symptoms.ital admissions for heart attacks and heart failure have been reduced by COVID-19 as people fear going to hospitals. Getty Images #COVIDUK #COVID19
News | Coronavirus (COVID-19)
Cardiovascular Admissions Reduced in U.K. During a Second Wave of COVID-19

February 24, 2021 — A study of admissions for acute myocardial infarction (AMI) and heart failure (HF) in the U.K ...

Home February 24, 2021
Home
The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
News | Heart Failure
Occlutech Completes Enrollment in Pilot Study of Heart Failure Atrial Flow Regulator

February 24, 2021 — Occlutech announced the completion of patient enrollment in the PRELIEVE trial, pilot study to ...

Home February 24, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now